Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Alan Lumsden, MD Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center Chair, Department of ...

Dr. Suresh Vedantham asks Drs. Pavan Kavali and Kristen Sanfilippo about possible benefits of a DVT response team model, ...

LINC is designed with multiple high-quality live cases from the world's leading interventional centers, presented through immersive dialogue wi ...

Acquisition expected to strengthen Stryker's neurovascular business with Inari VTE product portfolio including mechanical ...

(PEN), and while Penumbra has roughly 50% share in the DVT market, Inari has been the ... database on the safety and efficacy of mechanical thrombectomy, I believe this is a major growth market ...

Stryker (NYSE: SYK), a global leader in medical technologies, has announced its definitive agreement to acquire Inari Medical ...

Stryker has entered a definitive agreement to acquire medical device company Inari Medical for approximately $4.9 billion. Inari was founded in 2011 and focuses on mechanical thrombectomy solutions ...

Penumbra (PEN) stock rises as Stryker (SYK) agrees to acquire its rival in the thrombectomy market, Inari Medical (NARI) for $4.9B in cash. Read more here.

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.

Shares of Inari Medical catapulted to a 12-month high Monday on a report medical devices maker Stryker is in advanced talks to buy it.